Research suggests that GABA plays a well-established role in the brain's natural stress-dampening and anxiety-regulating systems, with several reviews linking disruptions in GABAergic signaling to conditions such as generalized anxiety disorder, epilepsy, and related psychiatric conditions. However, the evidence for oral GABA supplementation directly reducing anxiety or stress in humans is considerably less certain — a 2020 systematic review of 14 placebo-controlled trials found only limited support for stress reduction and even weaker evidence for other benefits, concluding that more rigorous research is needed. The most directly supportive human trial, a small 2024 randomized controlled trial of 30 women, reported improvements in mood and autonomic nervous system measures when GABA supplementation was combined with exercise, though its limited sample size tempers the strength of those findings. Taken together, the available evidence base consists largely of reviews, mechanistic research, and a small number of human trials, and while the underlying science is biologically plausible, studies do not yet provide sufficient grounds for firm conclusions about the effectiveness of supplemental GABA for anxiety relief in the general population.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Effects of Oral Gamma-Aminobutyric Acid (GABA) Administration on Stress and S... | Systematic review | 2020 | Mixed | 88 |
| GABA Supplementation, Increased Heart-Rate Variability, Emotional Response, S... | RCT | 2024 | Supports | 85 |
| Gamma-aminobutyric acid as a potential postbiotic mediator in the gut-brain a... | Review | 2024 | Supports | 80 |
| GABA, gamma-hydroxybutyric acid, and neurological disease. | Review | 2003 | Supports | 72 |
| A Comprehensive Review of the Generalized Anxiety Disorder. | Review | 2023 | Supports | 70 |
| [Stress-induced disorders]. | Other | 2020 | Supports | 68 |
| Aromas Influencing the GABAergic System. | Review | 2022 | Supports | 65 |
| Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. | Review | 2020 | Neutral | 65 |